Dimension Inx was recognized as a Finalist in the Small and
Might category of Fast Company's 2024 Innovation by Design Awards
for CMFlex™, the first 3D-printed regenerative bone product cleared
by the FDA.
CHICAGO, July 23,
2024 /PRNewswire-PRWeb/ -- Dimension Inx's first
commercial product, CMFlex™, was honored in Fast Company's
Innovation by Design Awards for 2024 in the Small and Mighty
category.
CMFlex offers an innovative, fully
synthetic regenerative solution that leverages a distinctive
material microstructure and macroarchitecture designed for rapid
vascularization and tissue integration to promote bone regeneration
and remodeling.
"We're deeply honored to be recognized by Fast Company for our
pioneering work developing CMFlex," said CEO of Dimension Inx,
Caralynn Nowinski Collens, M.D.
"This acknowledgment underscores our commitment to advancing the
next generation of biomaterial-based therapeutics – where 3D
printing, material science, and biology are combined to create
scalably manufactured products that restore tissue or organ
function in the body and improve patient outcomes."
CMFlex, the first 3D-printed regenerative bone product cleared
by the FDA, is a ready-to-use, flexible ceramic graft created for
bone reconstruction. It is currently indicated for procedures in
the mid to lower face, with expanded indications anticipated.
CMFlex offers an innovative, fully synthetic regenerative solution
that leverages a distinctive material microstructure and
macroarchitecture designed for rapid vascularization and tissue
integration to promote bone regeneration and remodeling.
"This groundbreaking innovation is a testament to the hard work,
dedication, and expertise of our incredible team. Their relentless
pursuit of excellence has made CMFlex a reality, offering a truly
novel product that improves clinician workflow, reduces surgical
case time, and restores healthy bone. We're excited by the interest
we've already received from surgeons who recognize its innovative
design that optimizes both biological function and ease of use,"
said Ramille Shah, Ph.D., CSO, Head
of R&D, and co-founder of Dimension Inx.
The Innovation by Design Awards honor the designers and
businesses solving the most crucial problems of today and
anticipating the pressing issues of tomorrow. It is one of the most
sought-after design awards in the industry. Entries are judged on
the key ingredients of innovation: functionality, originality,
beauty, sustainability, user insight, cultural impact, and business
impact.
Winners, finalists, and honorable mentions are featured online,
and winners and finalists are featured in the Summer issue of Fast
Company magazine, on newsstands July 30,
2024. To see the complete list, go to
https://www.fastcompany.com/innovation-by-design/list.
ABOUT DIMENSION INX
Dimension Inx is a tissue therapeutics company. We design,
develop, and manufacture regenerative solutions that restore tissue
and organ function to provide life-saving solutions for patients
facing currently incurable diseases like type 1 diabetes and liver
disease.
Our materials-centric approach enables biofunctionality without
compromising manufacturability. We precisely tune our biomaterials
to create clinical solutions not otherwise possible. We work
shoulder-to-shoulder with biotech partners to help solve their most
challenging materials problems, and internally develop regenerative
products for therapeutic applications with high unmet clinical
need.
Dimension Inx is proudly based in Chicago, IL. To learn more about our team and
our technology, please visit http://www.dimensioninx.com. To learn
more about CMFlex, please visit https://www.cmflex3d.com/.
Media Contact
Cole Johnson, Dimension Inx, 1
7738304920, colejohnson@dimensioninx.com,
https://www.dimensioninx.com/
View original content to download
multimedia:https://www.prweb.com/releases/cmflex-by-dimension-inx-is-named-a-finalist-in-fast-companys-2024-innovation-by-design-awards-302202305.html
SOURCE Dimension Inx